CMS GLP-1 pilot shows early uptake and health benefits for seniors, signaling broader weight-loss drug access

CMS launched a federal pilot program to expand access to GLP-1 weight-loss medications for seniors.

After about two months, early data show that enrollment is rising and participants report improvements such as weight loss and better glycemic control.

Officials say the initial results could inform future policy decisions on broader coverage of GLP-1 therapies for older adults.